PCR Press Releases

The PCR Press Office welcome enquiries about its Courses, initiatives and activities in interventional cardiovascular medicine.

Journalists attending EuroPCR 2017

For any press-related inquiries about EuroPCR: Contact us

About PCR

  • Find our more about PCR here.
  • Join the conversation all year long with @PCRonline on Twitter: not only do we enjoy speaking to you, we also love hearing from you!

9 results

EuroPCR 2017 Press Release: EuroPCR 2017 celebrates past successes to innovate for the future

Paris, France: EuroPCR 2017, the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), pushed back barriers in bringing together young and established interventional cardiologists to learn from past successes, build understanding and experience of new percutaneous interventional approaches, and develop innovations for the future at this year’s course held from 16 to 19 May 2017 at the Palais des Congrès in Paris, France.

EuroPCR 2017 Press Release: EuroPCR issues statement on bioresorbable stent (BRS) technologies

20 May 2017

EuroPCR supports ongoing development of BRS to meet patients’ needs

EuroPCR 2017 Press Release: Results with new bioresorbable stent (BRS) technologies

19 May 2017

Novel bioresorbable stent technologies pave the way for ongoing developments

EuroPCR 2017 Press Release: First European randomised trial of PCI vs. optimised medical therapy in CTO

18 May 2017

High success rate and low procedural risk with PCI in coronary chronic total occlusion

EuroPCR 2017 Press Release: Neurological events with TAVI and surgical valve replacement in intermediate-risk patients

18 May 2017

Patients at intermediate risk for surgery have lower stroke risk with TAVI than surgery

EuroPCR 2017 Press Release: Low risk with deferred revascularisation based on measures of intracoronary physiology

16 May 2017

Largest real-world dataset reports on deferred revascularisation in stable angina and ACS

EuroPCR 2017 Press Release: Switching to aspirin/clopidogrel following one month of new P2Y12 inhibitor/aspirin post-ACS

16 May 2017

Reduced bleeding risk with switched dual antiplatelet therapy one month after acute coronary syndrome

EuroPCR 2017 Press Release: EuroPCR 2017, the world-leading course for cardiovascular interventions

09 May 2017

EuroPCR 2017 Press Release: More than 12,000 interventional cardiologists, nurse, technicians, scientists and industry innovators from around the world will meet to share the latest developments, research, and best practice in treating cardiovascular conditions, including coronary and valvular heart disease and stroke, with minimally endovascular techniques.